A detailed history of Vawter Financial, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Vawter Financial, Ltd. holds 1,647 shares of ABBV stock, worth $289,180. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,647
Previous 1,647 -0.0%
Holding current value
$289,180
Previous $282 Million 15.14%
% of portfolio
0.2%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $263,223 - $299,918
1,647 New
1,647 $300 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $220,022 - $254,708
1,647 New
1,647 $246 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Vawter Financial, Ltd. Portfolio

Follow Vawter Financial, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vawter Financial, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vawter Financial, Ltd. with notifications on news.